Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZNCF) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Astrazeneca (AZNCF) over the last 17 years, with Q4 2025 value amounting to $59.1 billion.

  • Astrazeneca's Goodwill & Intangibles rose 152.23% to $59.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $59.1 billion, marking a year-over-year increase of 152.23%. This contributed to the annual value of $59.1 billion for FY2025, which is 152.23% up from last year.
  • As of Q4 2025, Astrazeneca's Goodwill & Intangibles stood at $59.1 billion, which was up 152.23% from $59.4 billion recorded in Q3 2025.
  • Astrazeneca's Goodwill & Intangibles' 5-year high stood at $90.9 billion during Q4 2021, with a 5-year trough of $31.8 billion in Q2 2021.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $59.1 billion (2022), whereas its average is $58.3 billion.
  • As far as peak fluctuations go, Astrazeneca's Goodwill & Intangibles surged by 26155.96% in 2021, and later tumbled by 3498.53% in 2022.
  • Over the past 5 years, Astrazeneca's Goodwill & Intangibles (Quarter) stood at $90.9 billion in 2021, then plummeted by 34.99% to $59.1 billion in 2022, then fell by 1.67% to $58.1 billion in 2023, then rose by 0.11% to $58.2 billion in 2024, then rose by 1.52% to $59.1 billion in 2025.
  • Its last three reported values are $59.1 billion in Q4 2025, $59.4 billion for Q3 2025, and $59.1 billion during Q2 2025.